IDENTIFICATION OF MIRNA IN CEREBROSPINAL FLUID AND PLASMA AS A BIOMARKER TO SUPPORT MRI EVALUATION AND MONITORING OF PEDIATRIC BRAIN TUMORS.

被引：0
|
作者：
Coyle, Anne [1 ]
Familiar, Ariana [1 ]
Zhao, Chao [1 ]
Rathi, Komal [1 ]
Hollawell, Madison [1 ]
Choudhari, Namrata [1 ]
Foster, Jessica [1 ]
Naqvi, Ammar [1 ]
Bagheri, Sina [2 ]
Anderson, Hannah [2 ]
Vidal, Lorenna [1 ]
Vossough, Arastoo [1 ]
Storm, Philip B. [1 ]
Madsen, Peter [1 ]
Resnick, Adam C. [1 ]
Nabavizadeh, Ali [2 ]
Koptyra, Mateusz [1 ]
机构：
[1] Childrens Hosp Philadelphia, Philadelphia, PA USA
[2] Hosp Univ Pennsylvania, Philadelphia, PA USA
来源：
NEURO-ONCOLOGY | 2022年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
BIOM-63
引用
收藏
页码：19 / 19
页数：1
相关论文
共 50 条
  • [21] Identification of a possible proteomic biomarker in Parkinson's disease: discovery and replication in blood, brain and cerebrospinal fluid
    Winchester, Laura
    Barber, Imelda
    Lawton, Michael
    Ash, Jessica
    Liu, Benjamine
    Evetts, Samuel
    Hopkins-Jones, Lucinda
    Lewis, Suppalak
    Bresner, Catherine
    Malpartida, Ana Belen
    Williams, Nigel
    Gentlemen, Steve
    Wade-Martins, Richard
    Ryan, Brent
    Holgado-Nevado, Alejo
    Hu, Michele
    Ben-Shlomo, Yoav
    Grosset, Donald
    Lovestone, Simon
    BRAIN COMMUNICATIONS, 2022, 5 (01)
  • [22] Brain-Derived Neurotrophic Factor in Cerebrospinal Fluid and Plasma as a Potential Biomarker for Huntington's Disease
    Ou, Zhen-Yi Andy
    Byrne, Lauren M.
    Rodrigues, Filipe B.
    Tortelli, Rosanna
    Johnson, Eileanor B.
    Foiani, Martha S.
    Arridge, Marzena
    De Vita, Enrico
    Scahill, Rachael I.
    Heslegrave, Amanda
    Zetterberg, Henrik
    Wild, Edward J.
    NEUROTHERAPEUTICS, 2019, 16 (04) : 1373 - 1374
  • [23] Pediatric preclinical testing consortium evaluation of the EZH2 inhibitor tazemetostat in orthotopic PDX models of pediatric brain tumors.
    Li, Xiao-Nan
    Qi, Lin
    Kogiso, Mari
    Lindsay, Holly Brianne
    Erickson, Stephen W.
    Guo, Yuelong
    Smith, Malcolm A.
    Teicher, Beverly A.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [24] Cerebrospinal Fluid/Plasma Albumin Ratio as a Biomarker for Blood-Brain Barrier Impairment Across Neurodegenerative Dementias
    Musaeus, Christian Sandoe
    Gleerup, Helena Sophia
    Hogh, Peter
    Waldemar, Gunhild
    Hasselbalch, Steen Gregers
    Simonsen, Anja Hviid
    JOURNAL OF ALZHEIMERS DISEASE, 2020, 75 (02) : 429 - 436
  • [25] Identification of apolipoprotein A-II in cerebrospinal fluid of pediatric brain tumor patients by protein expression profiling
    de Bont, Judith M.
    den Boer, Monique L.
    Reddingius, Roel E.
    Jansen, Jaap
    Passier, Monique
    van Schaik, Ron H. N.
    Kros, Johan M.
    Smitt, Peter A. E. Sllevis
    Luider, Theo H.
    Pieters, Rob
    CLINICAL CHEMISTRY, 2006, 52 (08) : 1501 - 1509
  • [26] Comparison of lumbar and shunt cerebrospinal fluid specimens for cytologic detection of leptomeningeal disease in pediatric patients with brain tumors
    Gajjar, A
    Fouladi, M
    Walter, AW
    Thompson, SJ
    Reardon, DA
    Merchant, TE
    Jenkins, JJ
    Liu, AY
    Boyett, JM
    Kun, LE
    Heideman, RL
    JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (06) : 1825 - 1828
  • [27] Evaluation of cerebrospinal fluid concentration and plasma free concentration as a surrogate measurement for brain free concentration
    Liu, Xingrong
    Smith, Bill J.
    Chen, Cuiping
    Callegari, Ernesto
    Becker, Stacey L.
    Chen, Xi
    Cianfrogna, Julie
    Doran, Angela C.
    Doran, Shawn D.
    Gibbs, John P.
    Hosea, Natilie
    Liu, Jianhua
    Nelson, Frederick R.
    Szewc, Mark A.
    Van Deusen, Jeffrey
    DRUG METABOLISM AND DISPOSITION, 2006, 34 (09) : 1443 - 1447
  • [28] Monitoring pediatric CNS non-germinomatous germ cell tumors via cerebrospinal fluid circulating tumor DNA
    Zhang, Yu-Tong
    Jin, Xian-Mei
    Zhong, Xiao-Dan
    Chang, Jian
    PEDIATRIC BLOOD & CANCER, 2024,
  • [29] Identification of tumor-related proteins by proteomic analysis of cerebrospinal fluid from patients with primary brain tumors
    Zheng, PP
    Luider, TM
    Pieters, R
    Avezaat, CJJ
    Van Den Bent, MJ
    Smitt, PAES
    Kros, JM
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2003, 62 (08): : 855 - 862
  • [30] LEVELS OF LYSOPHOSPHATIDIC ACIDS IN THE CEREBROSPINAL FLUID (BUT NOT PLASMA) CAN BE A SUITABLE BIOMARKER OF BLAST-INDUCED TRAUMATIC BRAIN INJURY
    Arun, Peethambaran
    Wilder, Donna
    Wang, Ying
    Morris, Andrew
    Sabbadini, Roger
    Long, Joseph
    JOURNAL OF NEUROTRAUMA, 2022, 39 (11-12) : A103 - A103
12345